投融资数据库
免费查数据
注册送3天会员
首页>投融资
BillionToOne
上市
Billiontoone Inc is a developer of a molecular counter platform intended to improve the resolution of cell-free DNA testing. The company's prenatal testing procedure focuses on quantitative biology and statistical learning methods to optimize the signal-to-noise ratio and detect single-gene disorders, enabling expecting mothers to detect disorders such as sickle-cell disease, beta-thalassemia, spinal muscular atrophy, and cystic fibrosis through a simple blood test.In December 2022, Billiontoone Inc announces it has secured an additional $48.5 million of funding from existing equity investors as well as upsized its Term Loan Facility with access to up to $35 million With this additional funding, gross proceeds will reach $280 million.In March 2022, BillionToOne Inc closed an oversubscribed Series C funding round of $125 million with premier global investors
基本信息
-
公司全称Billiontoone Inc
-
类型遗传病检测系统供应商
-
产业领域医疗器械
-
公司人数500人以上
-
地址1035 O'brien Drive MENLO PARK CALIFORNIA 94025; US; Telephone: +16504602551;
-
联系电话1-650-4602551
-
邮箱info@billiontoone.com
-
成立时间2016-01-01
投融资
-
2025-11-06
-
2024-09-04
-
2024-06-21
-
2022-03-30
-
2021-06-16
-
2020-03-10
-
2019-03-28
- 加载更多
相关投融资企业
D轮
ViCentra BV develops, manufactures and markets next generation insulin pumps and other products to treat people with diabetes.In December 2021, ViCentra BV announced the closing of a EUR 65 million (USD 74 million) Series C financing
C轮
Inquis Medical是一家专注于外周血管创新的临床阶段医疗器械公司，开发一种外周血栓切除医疗设备，旨在解决未满足的临床需求并提高护理标准。该公司的技术专注于改善静脉血栓栓塞性疾病的管理，并提供有效的单次血栓切除术，减少出血量，使客户能够拥有具有长期影响的医疗设备，以满足未满足的需求。
未公开
Synchrony Medical 是一家总部位于美国新泽西州、并在以色列设有研发基地的呼吸护理技术公司，由 MEDX Xelerator 孵化成立。公司推出的 LibAirty™ 气道清除系统——一款已获 FDA 批准的居家治疗设备——是在以色列谢巴医疗中心顶尖肺病专家合作下开发的，灵感源自成熟的自体引流（Autogenic Drainage）技术。LibAirty™ 通过同步控制呼吸与胸部按压，将复杂的气道清除治疗简化为患者可独立完成的日常护理，为支气管扩张症、囊性纤维化等慢性肺病患者树立了新的居家护理标准。
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息